Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature.
The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions.
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis.
Teriflunomide and its mechanism of action in multiple sclerosis.
Psychiatric symptoms accompanying multiple sclerosis onset: a case report.
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Comprehensive Identification of Long Non-coding RNAs in Purified Cell Types from the Brain Reveals Functional LncRNA in OPC Fate Determination.
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling.
Multi-Sectional Views Textural Based SVM for MS Lesion Segmentation in Multi-Channels MRIs.
Lack of association between CD226 genetic variants and inflammatory demyelinating diseases in Korean population.
Clinical and Magnetic Resonance Imaging (MRI) Distinctions Between Tumefactive Demyelination and Brain Tumors in Children.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
[Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
476
477
478
479
480
481
482
483
484
…
next ›
last »